Status:
COMPLETED
Metabolic Syndrome in Patients With First-episode Schizophrenia
Lead Sponsor:
Aarhus University Hospital
Conditions:
Metabolic Syndrome X
Schizophrenia
Eligibility:
All Genders
18-50 years
Brief Summary
The metabolic syndrome (MetS) is highly prevalent in patients with schizophrenia and is a major risk factor of type-2 diabetes, cardiovascular disease and early death. Genetic factors, antipsychotic m...
Eligibility Criteria
Inclusion
- Patients with ICD-10 diagnosed schizophrenia
Exclusion
- Antipsychotic medication \> 6 weeks before inclusion
- Physical disability
- Pregnancy
- IQ\< 55
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT00957294
Start Date
August 1 2009
End Date
April 1 2013
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Unit, Dep. Q of Affective Disorders, Aarhus University Hospital, Risskov
Aarhus, Risskov, Denmark, 8240